Stockscreener 앱 받기
8.1176
4.72%
0.3676
전일 마감가:
$7.75
열려 있는:
$7.82
하루 거래량:
75,968
Relative Volume:
0.03
시가총액:
$2.07M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+16.94%
1개월 성능:
+14.79%
6개월 성능:
+62.64%
1년 성능:
+0.00%
1일 변동 폭
$7.80
$8.2272
1주일 범위
$6.45
$8.2272
52주 변동 폭
$2.70
$18.00
Quantum Biopharma Ltd Stock (QNTM) Company Profile
명칭
Quantum Biopharma Ltd
전화
-
주소
-
QNTM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
8.11 | 2.07M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
157.25 | 68.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.35 | 47.71B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.59 | 46.12B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.41 | 18.55B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
296.06 | 13.40B | 2.76B | 1.11B | 898.10M | 22.77 |
Quantum Biopharma Ltd 주식(QNTM)의 최신 뉴스
Quantum BioPharma (QNTM) Files Amended Complaint Over Alleged Market Manipulation | QNTM Stock News - GuruFocus
Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing - The Manila Times
Quantum Biopharma Files $700M Lawsuit Against CIBC, RBC Over Stock Manipulation | QNTM Stock News - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Quantum BioPharma to Reveal Year-End Results and Key Regulatory Milestones in May 6 Update - Stock Titan
Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time - GlobeNewswire
Quantum BioPharma Ltd. to Host Business Update Conference Call on May 6, 2025 - Nasdaq
Quantum BioPharma adds Kevin Malone as advisor - Investing.com Australia
Quantum BioPharma adds Kevin Malone as advisor By Investing.com - Investing.com South Africa
Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor - The Manila Times
Quantum Biopharma Announces Advocate Against Naked Short - GlobeNewswire
Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin - Bluefield Daily Telegraph
Quantum BioPharma Strengthens Defense: Short Selling Expert Kevin Malone to Combat Market Manipulation - Stock Titan
Quantum BioPharma Announces RSU Grant and Debt Settlement - TipRanks
Quantum BioPharma Corporate Update - Newsfile
1 ‘Defensive’ Cathie Wood Stock to Buy While It’s at a ‘Great Entry Point’ - The Globe and Mail
West Fraser Timber Ltd Stock Analysis: Q1 2025 Earnings and Future Outlook - The Globe and Mail
Meta Platforms (META) Can Withstand an Advertising Slowdown, Says Citigroup - The Globe and Mail
Stocks Pressured by Fears of a Tariff-Induced Slowdown - The Globe and Mail
Why ServiceNow Stock Is Gaining Today - The Globe and Mail
What to Know About Jeff Bezos’ Secret EV Startup Slate Auto - The Globe and Mail
Allied Announces April 2025 Distribution - The Globe and Mail
Rocket Lab Stock (RKLB) Soars on Major Hypersonic Tech Deals with US and UK Governments - The Globe and Mail
Abbott Laboratories (ABT) Q1 Earnings: What To Expect - The Globe and Mail
BWXT Moving Forward to Support National Security, Domestic Uranium Enrichment Mission - The Globe and Mail
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhar - GuruFocus
Quantum BioPharma (QNTM) Prevails in Legal Dispute with Former C - GuruFocus
Lithium Argentina to Release First Quarter 2025 Results on May 14, 2025 - The Globe and Mail
Quantum BioPharma wins legal battle against former CEO By Investing.com - Investing.com South Africa
Market Analysis: April 14th, 2025 - The Globe and Mail
Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold - The Globe and Mail
3 Hot New IPOs Defying the 2025 Market Slump - The Globe and Mail
Canadian Insurance Market Remains Strong Amidst Market Volatility: Aon Report - The Globe and Mail
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to Ignore - The Globe and Mail
Quantum BioPharma Secures Legal Victory with $180,000 Award - TipRanks
Quantum BioPharma wins legal battle against former CEO - Investing.com
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario - GlobeNewswire
Latest: Court Upholds $2.8M Award in Quantum BioPharma's Favor Against Former CEO - Stock Titan
2 AI Stocks That Could Help Set You Up for Life - The Globe and Mail
3 ETFs to Save Your Portfolio Right Now - The Globe and Mail
Are These 3 Retail Stocks Oversold or Really in Trouble? - The Globe and Mail
Should You Buy ChargePoint While It's Below $0.70? - The Globe and Mail
BMO Announces Election of Board of Directors - The Globe and Mail
Stocks in play: Bonterra Energy Corp - The Globe and Mail
Time to Load Up on the New Look of SCHD - The Globe and Mail
1 Undervalued Growth Stock You Can Buy During the Stock Market Drop of 2025 - The Globe and Mail
3 Reasons to Avoid SWIM and 1 Stock to Buy Instead - The Globe and Mail
Quantum BioPharma Licensee Celly Nutrition Announces Landmark Pa - GuruFocus
Quantum BioPharma’s licensee expands retail reach with AATAC deal By Investing.com - Investing.com South Africa
Quantum BioPharma Licensee Celly Nutrition Partners With Asian American Trade Associations Council - marketscreener.com
Quantum BioPharma's licensee expands retail reach with AATAC deal By Investing.com - Investing.com India
Quantum Biopharma Ltd (QNTM) 재무 분석
Quantum Biopharma Ltd (QNTM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.38%
0.87%
자본화:
|
볼륨(24시간):